We are in the midst of a paradigm shift towards digital solutions for designing and running clinical trials. These tools and models, from generative AI to digital protocols, allow for easy exchange of information and offer insights to assist in trial design. In some cases, they can even increase the odds of a trial’s success. Monica Karpinski explores the potential of these novel approaches.